Certara’s Simcyp PBPK Modeling and Simulation Technology Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug

107

PRINCETON, N.J.–(BUSINESS WIRE)–Certara’s Simcyp PBPK modeling and simulation technology was used to demonstrate bioequivalence for the FDA approval of a complex generic drug…

 

 

 

 

 

http://www.businesswire.com/news/home/20190612005035/en/Certara%E2%80%99s-Simcyp-PBPK-Modeling-Simulation-Technology-Achieves/